Clinical case reports involving Amferia hydrogel dressings have been performed on infected chronic wounds in collaboration with two clinics in Germany and the Netherlands.
Together with Amferia, the clinics have performed five case evaluations of the Amferia hydrogel dressing in hard-to-heal infected wounds of one dog and four cats, all colonized with multi-resistant pseudomonas aeuruginosa or MRSA bacteria.
All wounds were open wounds from either trauma or chronic complications, and the patients suffered from recurring wound complications over a period of two to three months. The attending wound specialist requested Amferia dressing for trials on the patients and noted a clear effect within 24 hours, noting bio-burden reduction and formation of new granulation tissue.
